LONDON (Reuters) - Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.
from Reuters: Most Read Articles http://ift.tt/1AYEj4w http://www.reuters.com
from Reuters: Most Read Articles http://ift.tt/1AYEj4w http://www.reuters.com
No comments:
Post a Comment